Yüklüyor......
Review of Toyoda K, et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischemic stroke in Japan. Lancet Neurol. 2019 Jun;18(6):539-548
BACKGROUND: Prior meta-analyses showed that treatment with cilostazol, with or without aspirin, significantly reduced the incidence of recurrent ischemic stroke, occurrence of hemorrhagic stroke, and frequency of other serious vascular adverse events. METHODS: This review highlights the value of the...
Kaydedildi:
| Yayımlandı: | Surg Neurol Int |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Scientific Scholar
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7193192/ https://ncbi.nlm.nih.gov/pubmed/32363048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.25259/SNI_83_2020 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|